You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-AIF antibody [4E7]See all AIF primary antibodies ...
  • Description
    Mouse monoclonal [4E7] to AIF
  • Tested applicationsWB, ELISA, IHC-P, Flow Cyt, ICC/IF more details
  • Species reactivity
    Reacts with: Mouse, Rat, Human, African Green Monkey
  • Immunogen

    Purified recombinant fragment of Human AIF expressed in E. Coli.

  • Positive controlRecombinant AIF protein; NIH 3T3, Jurkat, HeLa, HepG2, MOLT4, C6, Raji, COS7 and PC12 cell lysate.

Properties

Applications

Our Abpromise guarantee covers the use of ab130240 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB WB: 1/500 - 1/2000. Predicted molecular weight: 67 kDa.
ELISA ELISA: 1/10000.
IHC-P IHC-P: 1/200 - 1/1000.
Flow Cyt Flow Cyt: 1/200 - 1/400.
ICC/IF ICC/IF: 1/200 - 1/1000.

Target

  • FunctionProbable oxidoreductase that has a dual role in controlling cellular life and death; during apoptosis, it is translocated from the mitochondria to the nucleus to function as a proapoptotic factor in a caspase-independent pathway, while in normal mitochondria, it functions as an antiapoptotic factor via its oxidoreductase activity. The soluble form (AIFsol) found in the nucleus induces 'parthanatos' i.e., caspase-independent fragmentation of chromosomal DNA. Interacts with EIF3G,and thereby inhibits the EIF3 machinery and protein synthesis, and activates casapse-7 to amplify apoptosis. Plays a critical role in caspase-independent, pyknotic cell death in hydrogen peroxide-exposed cells. Binds to DNA in a sequence-independent manner.
  • Involvement in diseaseDefects in AIFM1 are the cause of combined oxidative phosphorylation deficiency type 6 (COXPD6) [MIM:300816]. It is a mitochondrial disease resulting in a neurodegenerative disorder characterized by psychomotor delay, hypotonia, areflexia, muscle weakness and wasting.
  • Sequence similaritiesBelongs to the FAD-dependent oxidoreductase family.
  • Post-translational
    modifications
    Under normal conditions, a 54-residue N-terminal segment is first proteolytically removed during or just after translocation into the mitochondrial intermembrane space (IMS) by the mitochondrial processing peptidase (MPP) to form the inner-membrane-anchored mature form (AIFmit). During apoptosis, it is further proteolytically processed at amino-acid position 101 leading to the generation of the mature form, which is confined to the mitochondrial IMS in a soluble form (AIFsol). AIFsol is released to the cytoplasm in response to specific death signals, and translocated to the nucleus, where it induces nuclear apoptosis in a caspase-independent manner.
  • Cellular localizationMitochondrion intermembrane space. Mitochondrion inner membrane. Cytoplasm. Nucleus. Cytoplasm > perinuclear region. Proteolytic cleavage during or just after translocation into the mitochondrial intermembrane space (IMS) results in the formation of an inner-membrane-anchored mature form (AIFmit). During apoptosis, further proteolytic processing leads to a mature form, which is confined to the mitochondrial IMS in a soluble form (AIFsol). AIFsol is released to the cytoplasm in response to specific death signals, and translocated to the nucleus, where it induces nuclear apoptosis. Colocalizes with EIF3G in the nucleus and perinuclear region.
  • Target information above from: UniProt accession O95831 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      AIFM1 antibodyAIFM1_HUMAN antibodyApoptosis inducing factor 1, mitochondrial antibody
      Apoptosis inducing factor antibodyApoptosis inducing factor antibodyApoptosis inducing factor, mitochondrion associated, 1 antibodyApoptosis-inducing factor 1 antibodyCOXPD6 antibodyHarlequin antibodyHarlequin antibodyHq antibodyHq antibodymAIF antibodymAIF antibodyMGC111425 antibodyMGC5706 antibodyMGC5706 antibodymitochondrial antibodyPDCD 8 antibodyPDCD8 antibodyPDCD8 antibodyProgrammed cell death 8 (apoptosis inducing factor) antibodyProgrammed cell death 8 antibodyProgrammed cell death 8 isoform 1 antibodyProgrammed cell death 8 isoform 1 antibodyProgrammed cell death 8 isoform 2 antibodyProgrammed cell death 8 isoform 2 antibodyProgrammed cell death 8 isoform 3 antibodyProgrammed cell death 8 isoform 3 antibodyProgrammed cell death protein 8 antibodyProgrammed cell death protein 8 mitochondrial antibodyProgrammed cell death protein 8 mitochondrial precursor antibodyProgrammed cell death protein 8 mitochondrial precursor antibodyStriatal apoptosis inducing factor antibody
    see all

Anti-AIF antibody [4E7] images

  • Anti-AIF antibody [4E7] (ab130240) at 1/500 dilution + recombinant AIF protein.

    Predicted band size : 67 kDa
  • All lanes : Anti-AIF antibody [4E7] (ab130240) at 1/500 dilution

    Lane 1 : NIH 3T3 cell lysate
    Lane 2 : Jurkat cell lysate
    Lane 3 : HeLa cell lysate
    Lane 4 : HepG2 cell lysate
    Lane 5 : MOLT4 cell lysate
    Lane 6 : C6 cell lysate
    Lane 7 : Raji cell lysate
    Lane 8 : Cos7 cell lysate
    Lane 9 : PC12 cell lysate


    Predicted band size : 67 kDa

References for Anti-AIF antibody [4E7] (ab130240)

ab130240 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab130240.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"